From Synthesis Partner to UK Bench: Writing SPPS Release Checks into a Laboratory SOP

Every controlled in-vitro study rests on a paper trail as much as on a pipette. When a supplier changes the way it describes its solid-phase peptide synthesis (SPPS) partners and its UK release checks, the laboratory SOP that governs purchasing, receipt, storage and documentation has to move with it. The notes below follow the wording Research Sciences currently publishes, and suggest how a research group can translate that wording into SOP clauses without overstating what any catalogue page or certificate actually proves. Materials remain research-use-only throughout: not for human or veterinary use, and not for diagnostic or clinical application.

How the Supplier Describes Its SPPS Manufacturing Partners

The published FAQs state that compounds are manufactured by international partners using solid-phase peptide synthesis, then independently tested by HPLC and subjected to final verification and quality checks in the UK before release. That sentence is the anchor for any SOP revision, because it defines the two halves of the supply chain a laboratory is implicitly relying on: synthesis abroad, release verification domestically. What the site does not do is name an individual synthesis partner against each catalogue item. Materials managers should therefore resist the temptation to write a partner name into a standard operating procedure on the basis of assumption. The defensible wording is to record what is documented for the batch in hand — the certificate of analysis (CoA), the internal test reference (ITR) where one is quoted, and the vial label reference — and to state explicitly that the synthesis partner is described by the supplier collectively rather than per lot.

The FAQ also notes that all peptides contain trace amounts of mannitol, an excipient described as helping the vial not to look empty, supporting stability during lyophilisation, aiding solubility and offering protection in storage. For a laboratory SOP this is not a trivial detail. It belongs in the weighing and solubility section, because an excipient present in the lyophilised cake affects how a vial is handled at the bench and how a stock concentration is approached for an in-vitro assay. Recording the excipient as supplier-stated, rather than ignoring it, keeps the SOP honest about what is in the vial beyond the peptide itself.

Two further clarifications from the FAQs deserve their own SOP clause. First, vial labels follow a reference format that combines the SKU code with an expiry date, for example BPC10-03/27, and that reference links to the corresponding CoA; the reference should be quoted whenever documentation is queried. Second, restocked products may carry the same ITR as earlier stock. An ITR links to associated sample testing reports, but it does not confirm that separate deliveries come from the same production lot or that they have undergone separate independent testing. Cap colours and other packaging may also vary, and cap colour is not an indicator of identity, analytical quality or manufacturing origin. An SOP that treats cap colour as a visual check is an SOP with a built-in error.

The UK Release Checks a Supplier Describes — and How to Record Them

The supplier’s stated position is that every compound is accompanied by a CoA covering purity and identity by HPLC, supported by a broader testing framework described on the About page as full-spectrum evaluation of submitted samples: purity, identity, heavy metals and endotoxin. Site-published educational material, including posts dated March 2026, discusses CoAs, HPLC, heavy-metal testing by ICP-MS and endotoxin testing. Where a laboratory wants to cite those methods in its own documentation, it should do so as the shop’s published guidance and not as a validated method transfer. No pass/fail limits, certificate numbers or additional laboratory methods should be inferred beyond what the batch CoA actually states.

The homepage lists CoAs Janoshik Analytical Reports alongside claims of ≥99% verified purity, UK research materials over 99.1% purity, 3,000+ UK orders, 24hr UK delivery and 7 days expert customer support. These are the shop’s current published figures and marketing lines, not independently audited numbers, and every one of them should be reconfirmed on the live site before it is quoted in an SOP or a supplier qualification record. The same applies to purity: the FAQs say peptides are typically supplied at ≥99% purity by HPLC, with the exact figure stated on the CoA. A procedure should direct the analyst to the batch CoA — and to the Janoshik report where the homepage listing applies to that batch — rather than to a headline percentage. Delivery in particular should be written as an estimate, since Royal Mail Tracked 24 usually delivers the following working day according to Royal Mail, and peak periods vary.

One further point shapes release acceptance: the shop states that it does not supply blended peptides, recommending instead that items be bought individually and combined only within a controlled experimental design. If a SOP covers multi-component in-vitro work, the receiving check should confirm that single-vial items were ordered as separate lines, and the combination step should sit inside the experimental design section rather than being assumed at the point of purchase. Throughout, the materials remain labelled “For Research Use Only – Not for Human Consumption”, a position the shop describes as in line with MHRA guidance; that wording should appear verbatim in the SOP’s scope statement, alongside the reminder that purchasers are responsible for lawful use, safe handling, storage, disposal and COSHH compliance.

Turning Those Descriptions into SOP Language: A Section-by-Section Template

Receipt and documentation

On receipt, the SOP should require the label reference to be read and transcribed exactly, matched against the CoA supplied with the batch, and the ITR recorded where quoted. Items should remain quarantined until documentation is confirmed, with a note that cap colour is not a verification step and that a matching ITR is not evidence of a shared production lot. The SOP should also state that the supplier describes UK-based final verification and quality checks before release, and that this description should be re-verified against current supplier wording at each annual review. Where items are sourced for a new study, reviewers can check live listings under Buy peptides uk and then open the individual product page and its CoA before adding an item to the approved list.

Storage and in-vitro handling

The FAQ quick guide gives the storage clauses directly: allow vials to reach room temperature before opening, work in a clean environment, remove only the amount required for the experiment, store lyophilised peptides at –20°C or below, sealed with desiccant and protected from moisture, heat and light, and avoid repeated freeze–thaw cycles. Reconstituted material is described as less stable and should be held at 2–8°C for short-term laboratory use. Where reconstitution is part of an in-vitro workflow, the SOP should specify diluent volume and target assay concentration only, note that peptide and solvent are allowed to reach ambient temperature first, and state that the free reconstitution calculator and all materials are for laboratory research only and must never be used for human or veterinary dosing.

Ordering, payment and dispatch

Payment is described as Pay-By-Bank / Open Banking through providers such as Wallid, regulated by the FCA, with no card payments accepted because research-use-only scientific materials fall into high-risk merchant categories; the shop states that it does not store bank login details. Orders are described as dispatched the next working day with tracking issued after dispatch, and returns are not accepted once dispatched, with refunds limited to damage, incorrect supply or quality issues under the Refunds & Returns Policy. Appendix the SOP with those terms, flag them for reconfirmation at checkout, and close with the standing reminder that all items are not for human or veterinary use.